The global Cancer Diagnostics Market is growing at an accelerated pace
Cancer
diagnostics involve various tests and procedures used to detect different types
of cancers as early as possible to help improve treatment outcomes. From simple
blood tests and imaging scans to biopsies and molecular testing, cancer
diagnostics help doctors determine if an individual has cancer, where it is
located in the body, if it has spread, and other important information. The
growing incidences of various cancers like breast, lung, prostate and
colorectal cancer globally have increased the demand for advanced and effective
diagnostic procedures. Early detection is critical for cancers to treat them
effectively and improve chances of survival.
The global Cancer Diagnostics Market is estimated to be valued at US$ 59.1 Bn
in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023
to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Immunohistochemistry
is one of the key diagnostic trends gaining popularity in the Global cancer diagnostics size.
Immunohistochemistry helps pathologists determine the exact types of cancer
cells present in a tissue sample. It works by detecting proteins or markers on
the surface of cancer cells that can help identify whether the cells came from
a certain type of cancer like breast, lung or blood cancer. With the rising
application of immunohistochemistry for diagnosing different cancer types, it
is driving significant growth of the overall cancer diagnostics market during
the forecast period. Better identification of cancer cell markers help doctors
customize treatment plans specific to each patient's type and stage of cancer.
Segment Analysis
The
global cancer diagnostics market is dominated by imaging and molecular
diagnostics segments. The imaging segment leads the market owing to ability of
imaging techniques like X-ray, magnetic resonance imaging (MRI), computed
tomography (CT), mammography, positron emission tomography (PET), and
ultrasound to non-invasively detect and monitor cancer internally within the
body. Molecular diagnostics segment is expected to witness the highest growth
during the forecast period due to continuous incorporation of latest
technologies like genetics, proteomics and bioinformatics for cancer diagnosis
at its early stages.
Key Takeaways
The
global cancer diagnostics market size is expected to witness high growth during
2023-2030. Regional analysis reveals that North America dominates the market
currently and is expected to retain its position during the forecast period.
Factors such as increasing incidence of cancer, rising adoption of advanced imaging
technologies and growing importance of early cancer diagnosis drive the
regional market growth. Europe follows North America in terms of market share
due to rising government initiatives to spread cancer awareness and support
cancer research activities. Asia Pacific is anticipated to witness the fastest
growth rate during the forecast period owing to large patient population,
growing healthcare expenditure and improving healthcare infrastructure in
emerging economies like China and India.
Key players operating in the cancer diagnostics market are Sika Ag, Trelleborg
Ab, Henkel Ltd., Flexcon Company, Inc, Nitto Denko Corporation, Pyrotek Inc.,
Vibratec, Autoneum, Rousch, Avery Dennison Corporation, American Acoustical
Products, Polymer Technology Inc. Soundown Corporation, Heathcote Industrial
Plastics, Vibracoustic Gmbh, Megasorber Pty Ltd, and 3M. The key players are
involved in new product launches, collaborations and acquisitions to strengthen
their position in the market. For instance, In June 2022, Sika AG launched
SikaGard 804, a new product line of durable, easy to install acoustic blankets
for engine compartments to control exterior engine noise.
Get More Insights On This Topic: https://www.newsstatix.com/cancer-diagnostics-market-size-share-analysis-2023-2030/
Comments
Post a Comment